We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.24%
2 Consumer Discretionary 7.38%
3 Financials 6.38%
4 Healthcare 5.93%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BERY
4026
DELISTED
Berry Global Group, Inc.
BERY
$13K ﹤0.01%
244
-42
-15% -$2.33K
LEV
4027
DELISTED
The Lion Electric Company
LEV
$13K ﹤0.01%
6,913
-3,718
-35% -$8.4K
MCBC
4028
DELISTED
Macatawa Bank Corp
MCBC
$13K ﹤0.01%
1,250
+497
+66% +$5.28K
OMIC
4029
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$13K ﹤0.01%
351
-586
-63% -$35.9K
AMJ
4030
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$13K ﹤0.01%
574
+39
+7% +$880
VIA
4031
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$13K ﹤0.01%
684
+7
+1% +$197
AGTI
4032
DELISTED
Agiliti Inc
AGTI
$13K ﹤0.01%
799
+345
+76% +$5.94K
THRX
4033
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$13K ﹤0.01%
1,418
-3,732
-72% -$36.6K
RAD
4034
DELISTED
Rite Aid Corporation
RAD
$13K ﹤0.01%
6,030
-11,528
-66% -$38.2K
VCSA
4035
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$13K ﹤0.01%
684
-95
-12% -$2.67K
SAL
4036
DELISTED
Salisbury Bancorp, Inc.
SAL
$13K ﹤0.01%
572
-476
-45% -$13.5K
CPUH.U
4037
DELISTED
Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant
CPUH.U
$13K ﹤0.01%
1,289
-800
-38% -$8.24K
XM
4038
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
$13K ﹤0.01%
724
-5,293
-88% -$80.9K
CYXT
4039
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
$13K ﹤0.01%
41,560
+23,911
+135% +$50.5K
DBGI
4040
Digital Brands Group
DBGI
$8.64M
0
UBA
4041
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$13K ﹤0.01%
759
-11,288
-94% -$202K
ABOS icon
4042
Acumen Pharmaceuticals
ABOS
$193M
$12K ﹤0.01%
3,022
-250
-8% -$1.31K
AFCG
4043
AFC Gamma
AFCG
$72.1M
$12K ﹤0.01%
1,512
-2,032
-57% -$20.7K
ALZN icon
4044
Alzamend Neuro
ALZN
$7.43M
$12K ﹤0.01%
22
+9
+69% +$6.77K
AMPG icon
4045
AmpliTech
AMPG
$101M
$12K ﹤0.01%
4,641
-1,146
-20% -$2.87K
AOMR
4046
Angel Oak Mortgage REIT
AOMR
$207M
$12K ﹤0.01%
1,643
-2,705
-62% -$20K
AORT icon
4047
Artivion
AORT
$1.42B
$12K ﹤0.01%
886
-4,898
-85% -$62.6K
ATER icon
4048
Aterian
ATER
$5.44M
$12K ﹤0.01%
1,120
-671
-37% -$8.98K
BCBP icon
4049
BCB Bancorp
BCBP
$163M
$12K ﹤0.01%
897
-4,787
-84% -$79.4K
BEAT icon
4050
Heartbeam
BEAT
$27.7M
$12K ﹤0.01%
5,164
+1,295
+33% +$4.55K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.